Correlation Between Vitrolife and Ziccum AB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vitrolife and Ziccum AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vitrolife and Ziccum AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vitrolife AB and Ziccum AB, you can compare the effects of market volatilities on Vitrolife and Ziccum AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vitrolife with a short position of Ziccum AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vitrolife and Ziccum AB.

Diversification Opportunities for Vitrolife and Ziccum AB

0.85
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Vitrolife and Ziccum is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Vitrolife AB and Ziccum AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ziccum AB and Vitrolife is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vitrolife AB are associated (or correlated) with Ziccum AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ziccum AB has no effect on the direction of Vitrolife i.e., Vitrolife and Ziccum AB go up and down completely randomly.

Pair Corralation between Vitrolife and Ziccum AB

Assuming the 90 days trading horizon Vitrolife AB is expected to generate 0.43 times more return on investment than Ziccum AB. However, Vitrolife AB is 2.32 times less risky than Ziccum AB. It trades about 0.01 of its potential returns per unit of risk. Ziccum AB is currently generating about -0.04 per unit of risk. If you would invest  23,363  in Vitrolife AB on November 2, 2024 and sell it today you would earn a total of  137.00  from holding Vitrolife AB or generate 0.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Vitrolife AB  vs.  Ziccum AB

 Performance 
       Timeline  
Vitrolife AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vitrolife AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Vitrolife is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Ziccum AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ziccum AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Vitrolife and Ziccum AB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vitrolife and Ziccum AB

The main advantage of trading using opposite Vitrolife and Ziccum AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vitrolife position performs unexpectedly, Ziccum AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ziccum AB will offset losses from the drop in Ziccum AB's long position.
The idea behind Vitrolife AB and Ziccum AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals